GB1230663A
(da)
|
1968-12-10 |
1971-05-05 |
|
|
GB1356789A
(en)
|
1970-08-06 |
1974-06-12 |
Prodotti Antibiotici Spa |
Derivatives of theophylline
|
DE2050657C3
(de)
|
1970-10-15 |
1974-06-20 |
Basf Ag, 6700 Ludwigshafen |
Azofarbstoffe, Verfahren zu ihrer Herstellung und deren Verwendung
|
US3970753A
(en)
|
1973-06-12 |
1976-07-20 |
Smith Kline & French Laboratories Limited |
Imidazo[1,2-a]pyridines
|
DE2361390A1
(de)
|
1973-12-10 |
1975-06-19 |
Merck Patent Gmbh |
Isochinolinderivate und verfahren zu ihrer herstellung
|
DE2832677A1
(de)
|
1978-07-26 |
1980-02-07 |
Bayer Ag |
Hydroxypropyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
US4246274A
(en)
|
1978-05-10 |
1981-01-20 |
Bayer Aktiengesellschaft |
Antimycotic hydroxypropyl-imidazoles
|
DE3210570A1
(de)
|
1982-03-23 |
1983-10-06 |
Hoechst Ag |
3-azolyl-1,2-diaryl-1-halogen-1-propene, ihre herstellung, ihre verwendung als pflanzenschutzmittel und diese verbindungen enthaltende praeparate
|
US4703056A
(en)
|
1983-01-21 |
1987-10-27 |
Alkaloida Vegyeszeti Gyar |
New alkyl diamine derivatives
|
DE3650349T2
(de)
|
1985-03-15 |
1995-12-14 |
Antivirals Inc |
Immunotestmittel für polynukleotid und verfahren.
|
DE3628545A1
(de)
|
1985-09-23 |
1987-04-23 |
Hoechst Ag |
Arylmethylazole und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
|
JPH07100688B2
(ja)
|
1986-02-12 |
1995-11-01 |
大日本製薬株式会社 |
環状アミン誘導体
|
CA1317599C
(en)
|
1986-03-26 |
1993-05-11 |
Yukio Nezu |
1,2,6-triphenyl-4(1h)-pyridinone derivatives, production and uses thereof
|
DE3631013A1
(de)
|
1986-09-12 |
1988-03-24 |
Thomae Gmbh Dr K |
Neue naphthylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
DE3879024T2
(de)
|
1987-07-31 |
1993-10-07 |
Takeda Chemical Industries Ltd |
Pyridinium-Derivate, ihre Herstellung und Verwendung.
|
US5210266A
(en)
|
1987-12-03 |
1993-05-11 |
Dainippon Pharmaceutical Co., Ltd. |
N-substituted mercaptopropanamide derivatives
|
US5179125A
(en)
|
1987-12-03 |
1993-01-12 |
Dainippon Pharmaceutical Co., Ltd. |
N-substituted mercaptopropanamide derivatives
|
GB8820231D0
(en)
*
|
1988-08-25 |
1988-09-28 |
Fujisawa Pharmaceutical Co |
New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same
|
FR2638747B1
(fr)
|
1988-11-08 |
1993-12-24 |
Synthelabo |
Derives de phenyloxypropanolamines, leur preparation et leur application en therapeutique
|
DE3901723A1
(de)
|
1989-01-21 |
1990-07-26 |
Bayer Ag |
Azolyl-derivate
|
JP2769711B2
(ja)
|
1989-02-17 |
1998-06-25 |
昭和電工株式会社 |
オレフィン重合用触媒成分の製造方法及びオレフィンの重合方法
|
WO1991000537A1
(de)
|
1989-07-04 |
1991-01-10 |
Kumpf, Ursula |
Verfahren und einrichtung zum einziehen von insbesondere lichtwellenleiterkabeln in schutzrohre
|
PT95692A
(pt)
|
1989-10-27 |
1991-09-13 |
American Home Prod |
Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
|
US5420289A
(en)
|
1989-10-27 |
1995-05-30 |
American Home Products Corporation |
Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
|
US5229516A
(en)
|
1989-10-27 |
1993-07-20 |
American Home Products Corporation |
Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
|
US5244908A
(en)
|
1990-07-30 |
1993-09-14 |
Takeda Chemical Industries, Ltd. |
Imidazopyridine derivatives and their pharmaceutical use
|
EP0547231B1
(en)
|
1991-07-03 |
1996-08-28 |
Shionogi & Co., Ltd. |
Phospholipase a2 inhibitor
|
FI924053A
(fi)
|
1991-09-14 |
1993-03-15 |
Hoechst Ag |
Substituerade aminopropaner, foerfarande foer deras framstaellning och deras anvaendning
|
US5273980A
(en)
|
1991-09-30 |
1993-12-28 |
Merck Frosst Canada Inc. |
Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis
|
CA2079374C
(en)
|
1991-09-30 |
2003-08-05 |
Merck Frosst Canada Incorporated |
(bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
US5330989A
(en)
|
1991-10-24 |
1994-07-19 |
American Home Products Corporation |
Heterocycles substituted with biphenyl-3-cyclobutene-1,2-dione derivatives
|
CA2125570A1
(en)
|
1991-12-10 |
1993-06-24 |
Frank Zurmuhlen |
Pyrimidinyl- or triazinyl-oxy(or thio)aldehyde derivatives and their use as herbicides or plant-growth regulators
|
GB9206757D0
(en)
|
1992-03-27 |
1992-05-13 |
Ferring Bv |
Novel peptide receptor ligands
|
DE4227522A1
(de)
|
1992-08-20 |
1994-02-24 |
Bayer Ag |
Lichtpolarisierende Folien und neue dichroitische Farbstoffe hierfür
|
JP3298954B2
(ja)
|
1992-12-16 |
2002-07-08 |
三共株式会社 |
新規n,n’−ジベンゾイルヒドラジン誘導体及び殺虫組成物
|
US5484926A
(en)
|
1993-10-07 |
1996-01-16 |
Agouron Pharmaceuticals, Inc. |
HIV protease inhibitors
|
DK0691959T3
(da)
|
1993-03-29 |
1999-04-26 |
Zeneca Ltd |
Heterocykliske derivater som blodpladeaggregations-inhibitorer
|
IL109220A0
(en)
|
1993-04-05 |
1994-07-31 |
Synaptic Pharma Corp |
Dihydropyridines and new uses thereof
|
EP0700389A1
(en)
|
1993-05-27 |
1996-03-13 |
Smithkline Beecham Laboratoires Pharmaceutiques |
Anti-arrhythmic n-substituted 3-benzazepines or isoquinolines
|
FR2706895A1
(en)
|
1993-06-22 |
1994-12-30 |
Synthelabo |
Tetrahydroisoquinoline derivatives, their preparation and their application in therapeutics
|
JPH07179402A
(ja)
|
1993-10-20 |
1995-07-18 |
Ishihara Sangyo Kaisha Ltd |
置換ベンゼン誘導体、その製造方法及びそれを含有する有害生物防除剤
|
US5461154A
(en)
|
1994-02-02 |
1995-10-24 |
Eli Lilly And Company |
Intermediate and process for making
|
TW281667B
(da)
|
1994-02-03 |
1996-07-21 |
Synthelabo |
|
GB9402807D0
(en)
|
1994-02-14 |
1994-04-06 |
Xenova Ltd |
Pharmaceutical compounds
|
JPH07304770A
(ja)
|
1994-05-11 |
1995-11-21 |
Kanebo Ltd |
新規ベンゾアゼピノン誘導体
|
US5593994A
(en)
|
1994-09-29 |
1997-01-14 |
The Dupont Merck Pharmaceutical Company |
Prostaglandin synthase inhibitors
|
AU4368996A
(en)
|
1994-11-23 |
1996-06-17 |
Neurogen Corporation |
Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
|
US5541033A
(en)
|
1995-02-01 |
1996-07-30 |
Ocg Microelectronic Materials, Inc. |
Selected o-quinonediazide sulfonic acid esters of phenolic compounds and their use in radiation-sensitive compositions
|
US20030018025A1
(en)
|
1995-06-07 |
2003-01-23 |
Neurogen Corporation, Corporation Of The State Of Delaware |
Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives: new classes of dopamine receptor subtype specific ligands
|
US5554621A
(en)
|
1995-06-07 |
1996-09-10 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
|
EP0848957A1
(en)
|
1995-09-08 |
1998-06-24 |
Kanebo Ltd. |
Fas LIGAND SOLUBILIZATION INHIBITOR
|
AU1354097A
(en)
|
1995-12-29 |
1997-07-28 |
Smithkline Beecham Corporation |
Vitronectin receptor antagonists
|
WO1997040051A1
(en)
|
1996-04-24 |
1997-10-30 |
Takeda Chemical Industries, Ltd. |
Fused imidazopyridine derivatives as antihyperlipidemic agents
|
EP1473330B1
(en)
|
1996-07-17 |
2007-02-14 |
Fuji Photo Film Co., Ltd. |
Process for the synthesis of oxonol compound
|
GB9717576D0
(en)
|
1997-08-19 |
1997-10-22 |
Xenova Ltd |
Pharmaceutical compounds
|
HN1997000027A
(es)
|
1996-12-06 |
1997-06-05 |
Pfizer Prod Inc |
Derivados de 6-fenil piridil - 2 amina
|
HUP9700392A1
(hu)
|
1997-02-10 |
1999-09-28 |
ICN Magyarország Részvénytársaság |
Egy vagy két hatóanyagot tartalmazó kardioprotektív hatású gyógyszerkészítmények
|
US6048877A
(en)
|
1997-02-21 |
2000-04-11 |
Bristol-Myers Squibb Company |
Tetralone derivatives as antiarrhythmic agents
|
DK0971878T3
(da)
|
1997-02-27 |
2008-06-30 |
Takeda Pharmaceutical |
Aminforbindelser, fremstillingen og anvendelsen deraf som inhibitorer af amyloid-beta-produktion
|
DE19717371A1
(de)
|
1997-04-24 |
1998-10-29 |
Basf Ag |
Propargyl-terminierte, nematische oder cholesterische Polymere
|
CA2296476A1
(en)
|
1997-07-31 |
1999-02-11 |
Gianpiero De Cillis |
O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents
|
JPH11119379A
(ja)
|
1997-10-08 |
1999-04-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料および画像形成方法
|
AU3352899A
(en)
|
1997-12-11 |
1999-07-12 |
American Home Products Corporation |
2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
|
TW555757B
(en)
|
1998-07-31 |
2003-10-01 |
Akzo Nobel Nv |
Aminomethylcarboxylic acid derivatives
|
DE19834751A1
(de)
|
1998-08-01 |
2000-02-03 |
Boehringer Ingelheim Pharma |
Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel
|
CA2348159A1
(en)
|
1998-10-20 |
2000-04-27 |
Satoru Oi |
Aromatic amine derivatives, their production and use
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
US6357758B1
(en)
|
1999-06-30 |
2002-03-19 |
Federal-Mogul World Wide, Inc. |
Metal gasket and method of manufacturing
|
JP4603679B2
(ja)
|
1999-12-14 |
2010-12-22 |
日本化薬株式会社 |
害虫防除剤
|
GB0007108D0
(en)
|
2000-03-23 |
2000-05-17 |
Novartis Ag |
Organic compounds
|
US6534651B2
(en)
|
2000-04-06 |
2003-03-18 |
Inotek Pharmaceuticals Corp. |
7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
|
AU2001258771A1
(en)
|
2000-05-19 |
2001-11-26 |
Takeda Chemical Industries Ltd. |
-secretase inhibitors
|
US6846813B2
(en)
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
CA2410680A1
(en)
|
2000-06-30 |
2002-01-10 |
Elan Pharmaceuticals, Inc. |
Compounds to treat alzheimer's disease
|
US20020094989A1
(en)
|
2000-10-11 |
2002-07-18 |
Hale Jeffrey J. |
Pyrrolidine modulators of CCR5 chemokine receptor activity
|
US7125887B2
(en)
|
2000-10-11 |
2006-10-24 |
Merck & Co., Inc. |
Pyrrolidine modulators of CCR5 chemokine receptor activity
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
FR2822153B1
(fr)
|
2001-03-19 |
2003-10-31 |
Servier Lab |
Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
IL157093A0
(en)
|
2001-03-27 |
2004-02-08 |
Actelion Pharmaceuticals Ltd |
1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
|
FR2822827B1
(fr)
|
2001-03-28 |
2003-05-16 |
Sanofi Synthelabo |
Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant
|
CA2443868C
(en)
|
2001-04-10 |
2011-01-25 |
Ortho-Mcneil Pharmaceutical, Inc. |
1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
|
WO2002088089A1
(fr)
|
2001-04-19 |
2002-11-07 |
Banyu Pharmaceutical Co., Ltd. |
Derives de spiropiperidine, antagonistes du recepteur de nociceptine les contenant en tant qu'ingredient actif et compositions medicinales
|
EP1414810B1
(en)
|
2001-06-05 |
2006-08-30 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzo-fused cycloalkyl urea compounds
|
MXPA03011201A
(es)
|
2001-06-07 |
2004-02-26 |
Lilly Co Eli |
Moduladores de receptores activados por proliferadores de persoxisomas.
|
WO2003024976A2
(en)
|
2001-09-21 |
2003-03-27 |
Pharmacia & Upjohn Company |
Tricyclic indole derivatives as 5-ht ligands
|
DE60218511T2
(de)
|
2001-10-26 |
2007-10-25 |
Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.P.A. |
Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase
|
SE0103644D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic isoquinoline compounds
|
ATE297925T1
(de)
|
2001-11-20 |
2005-07-15 |
Lilly Co Eli |
3-substituierte oxindol beta 3 agonisten
|
JP2005518357A
(ja)
|
2001-11-20 |
2005-06-23 |
イーライ・リリー・アンド・カンパニー |
ベータ3アドレナリンアゴニスト
|
GB0202873D0
(en)
|
2002-02-07 |
2002-03-27 |
Novartis Ag |
Organic compounds
|
WO2003070732A1
(en)
*
|
2002-02-19 |
2003-08-28 |
Pharmacia & Upjohn Company |
Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
|
US6875780B2
(en)
|
2002-04-05 |
2005-04-05 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods for their preparation
|
JPWO2004011430A1
(ja)
|
2002-07-25 |
2005-11-24 |
アステラス製薬株式会社 |
ナトリウムチャネル阻害剤
|
EP1388342A1
(en)
|
2002-08-07 |
2004-02-11 |
Aventis Pharma Deutschland GmbH |
Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
|
UA80296C2
(en)
*
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
AU2003268512A1
(en)
|
2002-09-09 |
2004-03-29 |
Janssen Pharmaceutica N.V. |
Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
|
WO2004035579A1
(ja)
|
2002-10-15 |
2004-04-29 |
Takeda Pharmaceutical Company Limited |
イミダゾピリジン誘導体、その製造法および用途
|
CA2507026A1
(en)
|
2002-11-22 |
2004-06-10 |
Takeda Pharmaceutical Company Limited |
Imidazole derivatives, their production and use
|
AU2003294748A1
(en)
|
2002-12-06 |
2004-06-30 |
Bayer Healthcare Ag |
Tetrahydro-naphthalene derivatives
|
AU2003300358A1
(en)
|
2002-12-20 |
2004-07-22 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
WO2004078731A1
(fr)
|
2003-03-06 |
2004-09-16 |
'chemical Diversity Research Institute', Ltd. |
Acides quinoline-carboxyliques et leurs derives et bibliotheque focalisee
|
JP4317875B2
(ja)
|
2003-03-11 |
2009-08-19 |
フジフィルム・エレクトロニック・マテリアルズ・ユーエスエイ・インコーポレイテッド |
新規な感光性樹脂組成物
|
JP4226395B2
(ja)
|
2003-06-16 |
2009-02-18 |
アルパイン株式会社 |
音声補正装置
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
US7820673B2
(en)
|
2003-12-17 |
2010-10-26 |
Takeda Pharmaceutical Company Limited |
Urea derivative, process for producing the same, and use
|
US20050159334A1
(en)
|
2004-01-16 |
2005-07-21 |
Gluck Oscar S. |
Method for treating rheumatoid arthritis by inhibiting peptidylarginine deiminase
|
AU2005225471B2
(en)
|
2004-03-26 |
2011-05-12 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
TWI351282B
(en)
|
2004-04-07 |
2011-11-01 |
Theravance Inc |
Quinolinone-carboxamide compounds as 5-ht4 recepto
|
RU2266906C1
(ru)
|
2004-04-29 |
2005-12-27 |
Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") |
Анелированные карбамоилазагетероциклы, способы их получения (варианты), фармацевтическая композиция, фокусированная библиотека
|
GB0413605D0
(en)
|
2004-06-17 |
2004-07-21 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US7488745B2
(en)
|
2004-07-16 |
2009-02-10 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
EP1655283A1
(en)
|
2004-11-08 |
2006-05-10 |
Evotec OAI AG |
11beta-HSD1 Inhibitors
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
CN101080406A
(zh)
|
2004-12-22 |
2007-11-28 |
施万制药 |
吲唑-甲酰胺化合物
|
US7402596B2
(en)
|
2005-03-24 |
2008-07-22 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
DE102005016547A1
(de)
|
2005-04-08 |
2006-10-12 |
Grünenthal GmbH |
Substituierte 5,6,7,8-Tetrahydro-imidazo(1,2-a)pyridin-2-ylamin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
|
AR054363A1
(es)
|
2005-05-23 |
2007-06-20 |
Astrazeneca Ab |
Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
|
US7800123B2
(en)
|
2005-05-25 |
2010-09-21 |
Koninklijke Philips Electronics N.V. |
Electroluminescence device
|
AU2006252540B2
(en)
|
2005-06-02 |
2011-12-01 |
Jenrin Discovery |
MAO-B inhibitors useful for treating obesity
|
JP5086248B2
(ja)
|
2005-06-07 |
2012-11-28 |
セラヴァンス, インコーポレーテッド |
5−ht4受容体アゴニストとしてのベンゾイミダゾロン−カルボキサミド化合物
|
US7592461B2
(en)
|
2005-12-21 |
2009-09-22 |
Bristol-Myers Squibb Company |
Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
CN101384261B
(zh)
|
2005-12-22 |
2011-12-07 |
海德拉生物科学公司 |
治疗疼痛的组合物
|
BRPI0706560A2
(pt)
*
|
2006-01-17 |
2011-03-29 |
Hoffmann La Roche |
derivados de aril-isoxazol-4-il-imidazo [1,2-a] piridina úteis para o tratamento de doença de alzheimer por intermédio de receptores gaba
|
WO2007087548A2
(en)
|
2006-01-25 |
2007-08-02 |
Smithkline Beecham Corporation |
Chemical compounds
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
CA2646430A1
(en)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
RU2302417C1
(ru)
|
2006-03-14 |
2007-07-10 |
Иващенко Андрей Александрович |
1-оксо-3-(1н-индол-3-ил)-1,2,3,4-тетрагидроизохинолины, способы их получения, комбинаторная библиотека и фокусированная библиотека
|
CA2540218A1
(en)
|
2006-03-17 |
2007-09-17 |
Hafedh Trigui |
Asymmetric beams for spectrum efficiency
|
DE102006015449A1
(de)
|
2006-03-31 |
2007-10-04 |
Eads Deutschland Gmbh |
Selbstleuchtender Körper und Verfahren zu seiner Herstellung
|
RU2303597C1
(ru)
|
2006-05-12 |
2007-07-27 |
Иващенко Андрей Александрович |
Фармацевтическая композиция, способы ее получения и применения
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
WO2008000408A1
(en)
|
2006-06-28 |
2008-01-03 |
Sanofi-Aventis |
Cxcr2 antagonists
|
WO2008008059A1
(en)
|
2006-07-12 |
2008-01-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents ans uses thereof
|
DE102006039003A1
(de)
|
2006-08-19 |
2008-02-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Verbindungen
|
BRPI0718162A2
(pt)
|
2006-10-20 |
2013-11-26 |
Irm Llc |
Composição e métodos para modulara os receptores c-kit e pdgfr
|
WO2008064320A2
(en)
|
2006-11-21 |
2008-05-29 |
University Of Virginia Patent Foundation |
Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
|
BRPI0719280A2
(pt)
|
2006-11-27 |
2014-03-11 |
Lundbeck & Co As H |
Composto, composição farmacêutica, métodos para modular a atividade de um receptor de p2x7 in vitro e em um paciente, para tratar uma condição responsiva à modulação do receptor de p2x7 em um paciente, para inibir a morte de células do gânglio retinal em um paciente, para determinar a presença ou ausência de receptor de p2x7 em uma amostra, preparação farmacêutica acondicionada, método para tratar ou prevenir cirrose em um paciente, e, uso de um composto.
|
WO2008065500A2
(en)
|
2006-11-30 |
2008-06-05 |
Pfizer Products Inc. |
Heteroaryl amides as type i glycine transport inhibitors
|
CN101652352A
(zh)
|
2006-12-22 |
2010-02-17 |
诺瓦提斯公司 |
用于抑制pdk1的喹唑啉类
|
WO2008104077A1
(en)
|
2007-02-28 |
2008-09-04 |
Methylgene Inc. |
Small molecule inhibitors of protein arginine methyltransferases (prmts)
|
WO2008112715A2
(en)
|
2007-03-12 |
2008-09-18 |
Vm Discovery Inc. |
Novel agents of calcium ion channel modulators
|
WO2008121687A2
(en)
|
2007-03-28 |
2008-10-09 |
Array Biopharma Inc. |
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
|
US8273766B2
(en)
|
2007-04-04 |
2012-09-25 |
Kowa Company, Ltd. |
Tetrahydroisoquinoline compound
|
JP2008280344A
(ja)
|
2007-04-12 |
2008-11-20 |
Sumitomo Chemical Co Ltd |
ヒドラジド化合物及びそれを含有する有害節足動物防除剤
|
TW200902533A
(en)
|
2007-05-02 |
2009-01-16 |
Boehringer Ingelheim Int |
Carboxylic acid amides, manufacturing and use thereof as medicaments
|
EP2166841A4
(en)
|
2007-06-15 |
2014-05-07 |
Mission Pharma Co |
METHODS AND COMPOSITIONS FOR INHIBITING DOME FACTOR AND ADENYLYLCYCLASE
|
EP2172450B9
(en)
|
2007-06-20 |
2014-10-08 |
Mitsubishi Tanabe Pharma Corporation |
Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
|
RU2345996C1
(ru)
|
2007-07-17 |
2009-02-10 |
Андрей Александрович Иващенко |
Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
|
CA2695989A1
(en)
|
2007-08-10 |
2009-02-19 |
Glaxosmithkline Llc |
Certain nitrogen containing bicyclic chemical entities for treating viral infections
|
TW200922468A
(en)
|
2007-10-11 |
2009-06-01 |
Sumitomo Chemical Co |
α, β-unsaturated imine compound and use thereof for pest control
|
GB0720041D0
(en)
*
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
CN101873797A
(zh)
|
2007-10-19 |
2010-10-27 |
萨可德公司 |
用于治疗糖尿病性视网膜病的组合物和方法
|
EP2072050A1
(en)
|
2007-12-21 |
2009-06-24 |
Santhera Pharmaceuticals (Schweiz) AG |
Compounds with anti-emetic effect
|
JP2011507910A
(ja)
|
2007-12-21 |
2011-03-10 |
ユニバーシティー オブ ロチェスター |
真核生物の寿命を変更するための方法
|
FR2925902B1
(fr)
|
2008-01-02 |
2011-01-07 |
Sanofi Aventis |
DERIVES D'IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
|
RU2371444C1
(ru)
|
2008-01-24 |
2009-10-27 |
Андрей Александрович Иващенко |
ФУРО- И ТИЕНО[2,3-b]-ХИНОЛИН-2-КАРБОКСАМИДЫ, СПОСОБ ПОЛУЧЕНИЯ И ПРОТИВОТУБЕРКУЛЕЗНАЯ АКТИВНОСТЬ
|
AR070449A1
(es)
|
2008-02-22 |
2010-04-07 |
Otsuka Pharma Co Ltd |
Compuesto de benzodiazepina y composicion farmaceutica
|
JP2009209090A
(ja)
|
2008-03-04 |
2009-09-17 |
Mitsui Chemicals Inc |
殺虫剤及び該殺虫剤に含まれる化合物、並びに該化合物の使用方法
|
US20090276250A1
(en)
|
2008-05-01 |
2009-11-05 |
Travel Tech Systems, Llc |
Process and system to determine commercial airline arrivals
|
US8148408B2
(en)
|
2008-05-09 |
2012-04-03 |
Abbott Laboratories |
Selective substituted pyridine ligands for neuronal nicotinic receptors
|
WO2009140101A2
(en)
|
2008-05-12 |
2009-11-19 |
Boehringer Ingelheim International Gmbh |
Imidazopyridine compounds useful as mmp-13 inhibitors
|
JP2009274984A
(ja)
|
2008-05-14 |
2009-11-26 |
Sumitomo Chemical Co Ltd |
化合物、光学フィルムおよび光学フィルムの製造方法
|
US20100121052A1
(en)
|
2008-06-20 |
2010-05-13 |
Rama Jain |
Novel compounds for treating proliferative diseases
|
BRPI0920237A2
(pt)
|
2008-10-21 |
2015-12-29 |
Metabolex Inc |
agonistas do receptor aril gpr120 e suas respectivas utilizações
|
DE102008060958A1
(de)
|
2008-12-06 |
2010-07-08 |
Saltigo Gmbh |
Hydroxytetralone
|
RU2016116516A
(ru)
|
2008-12-08 |
2018-12-07 |
Мандифарма Интернэшнл Корпорейшн Лимитед |
Композиции ингибиторов тирозинкиназных рецепторов белков
|
US8367700B2
(en)
|
2008-12-17 |
2013-02-05 |
Gruenenthal Gmbh |
Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators
|
US20100204265A1
(en)
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
JP2012051806A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
イミダゾリルピラジン誘導体
|
CN104592219B
(zh)
|
2009-03-16 |
2017-04-12 |
住友化学株式会社 |
化合物、光学膜和光学膜的制造方法
|
JP5899607B2
(ja)
|
2009-03-16 |
2016-04-06 |
住友化学株式会社 |
化合物、光学フィルム及び光学フィルムの製造方法
|
AU2010232729A1
(en)
|
2009-03-31 |
2011-10-20 |
Arqule, Inc. |
Substituted indolo-pyridinone compounds
|
US20110077250A1
(en)
|
2009-06-26 |
2011-03-31 |
Ryder Sean |
Compounds for modulating rna binding proteins and uses therefor
|
JP5669481B2
(ja)
|
2009-08-21 |
2015-02-12 |
大塚製薬株式会社 |
医薬組成物
|
GB0914767D0
(en)
|
2009-08-24 |
2009-09-30 |
Sterix Ltd |
Compound
|
EP2357176A1
(en)
|
2010-01-15 |
2011-08-17 |
Hybrigenics S.A. |
Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
|
MX337169B
(es)
|
2010-02-11 |
2016-02-16 |
Celgene Corp |
Derivados de arilmetoxi isoindolina y composiciones que los comprenden y metodos para utilizar los mismos.
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
US9079880B2
(en)
|
2010-07-07 |
2015-07-14 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
US8697911B2
(en)
|
2010-07-07 |
2014-04-15 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
WO2012022045A1
(en)
|
2010-08-20 |
2012-02-23 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
CA2808543C
(en)
|
2010-08-20 |
2016-01-26 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
US20130203756A1
(en)
|
2010-10-29 |
2013-08-08 |
Jamie L. Bunda |
Isoindoline pde10 inhibitors
|
CA2822357A1
(en)
|
2010-12-22 |
2012-06-28 |
Abbvie Inc. |
Hepatitis c inhibitors and uses thereof
|
CN103827293A
(zh)
|
2011-06-29 |
2014-05-28 |
通用医疗公司 |
用于增强雌性生殖细胞中生物能状态的组合物和方法
|
AU2012276037A1
(en)
|
2011-06-29 |
2014-02-13 |
Mayo Foundation For Medical Education And Research |
Small molecule CD38 inhibitors and methods of using same
|
US9938269B2
(en)
|
2011-06-30 |
2018-04-10 |
Abbvie Inc. |
Inhibitor compounds of phosphodiesterase type 10A
|
JP2014198669A
(ja)
|
2011-08-03 |
2014-10-23 |
杏林製薬株式会社 |
ビアリールエステル誘導体、及びそれらを有効成分とする医薬
|
KR20140067048A
(ko)
|
2011-08-15 |
2014-06-03 |
인터뮨, 인크. |
라이소포스파티드산 수용체 길항제
|
US20130116241A1
(en)
|
2011-11-09 |
2013-05-09 |
Abbvie Inc. |
Novel inhibitor compounds of phosphodiesterase type 10a
|
AU2012358805B2
(en)
|
2011-12-22 |
2017-07-20 |
Gilead Sciences, Inc. |
Pyrazolo[1,5-a]pyrimidines as antiviral agents
|
CA2859869A1
(en)
|
2011-12-23 |
2013-06-27 |
Novartis Ag |
Compounds for inhibiting the interaction of bcl2 with binding partners
|
BR112014015274A8
(pt)
|
2011-12-23 |
2017-06-13 |
Novartis Ag |
compostos e composições para inibição da interação de bcl2 com parceiros de ligação
|
AU2012355624A1
(en)
|
2011-12-23 |
2014-07-17 |
Novartis Ag |
Compounds for inhibiting the interaction of BCL2 with binding partners
|
BR112014015308A2
(pt)
|
2011-12-23 |
2017-06-13 |
Novartis Ag |
compostos para inibição da interação de bcl2 com contrapartes de ligação
|
CZ2012114A3
(cs)
|
2012-02-17 |
2013-02-20 |
Zentiva, K.S. |
Zpusob prípravy rivaroxabanu zalozený na úspore 1,1´ -karbonyldiimidazolu
|
US8859541B2
(en)
|
2012-02-27 |
2014-10-14 |
Boehringer Ingelheim International Gmbh |
6-alkynylpyridines
|
JP6197031B2
(ja)
|
2012-05-24 |
2017-09-13 |
セルゾーム リミティッド |
Tyk2阻害剤としてのヘテロシクリルピリミジン類似体
|
EP2669276A1
(en)
|
2012-05-31 |
2013-12-04 |
Université de Strasbourg |
Ornithine- and lysine-derivatives for the treatment of pain
|
EP2864349A4
(en)
|
2012-06-20 |
2016-02-24 |
Univ California |
DYNAMIC BIOMIMETIC SYNZYM CATALYST, CATALYSIS AND CATALYST SYSTEMS
|
FR2993564B1
(fr)
|
2012-07-20 |
2014-08-22 |
Metabrain Res |
Derives d'imidazopyridine utiles dans le traitement du diabete
|
SI2877467T1
(sl)
*
|
2012-07-26 |
2017-02-28 |
Glaxo Group Limited |
2-(azaindol-2-il)benzimidazoli kot PAD4 inhibitorji
|
WO2014031872A2
(en)
|
2012-08-23 |
2014-02-27 |
The Broad Institute, Inc. |
Small molecule inhibitors for treating parasitic infections
|
AU2013305591B2
(en)
|
2012-08-24 |
2017-04-13 |
Board Of Regents Of The University Of Texas System |
Pro-neurogenic compounds
|
WO2014077321A1
(ja)
|
2012-11-15 |
2014-05-22 |
高砂香料工業株式会社 |
アルミニウム触媒
|
MX2015008052A
(es)
|
2012-12-21 |
2016-08-18 |
Epizyme Inc |
Inhibidores de prmt5 y sus usos.
|
WO2014100764A2
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Methods of inhibiting prmt5
|
WO2014152018A1
(en)
|
2013-03-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
FR3008976A1
(fr)
|
2013-07-23 |
2015-01-30 |
Servier Lab |
"nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent"
|
WO2015031295A1
(en)
|
2013-08-27 |
2015-03-05 |
Bristol-Myers Squibb Company |
Ido inhibitors
|
US9872852B2
(en)
|
2013-09-04 |
2018-01-23 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
GB201321730D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
GB201321746D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
WO2015108038A1
(ja)
|
2014-01-17 |
2015-07-23 |
第一三共株式会社 |
エチレングリコール化合物
|
TW201540711A
(zh)
|
2014-02-27 |
2015-11-01 |
Ono Pharmaceutical Co |
具有選擇性ep2促效劑活性的化合物
|
US9067898B1
(en)
|
2014-03-07 |
2015-06-30 |
Janssen Pharmaceutica Nv |
Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes
|
DK3119772T3
(da)
|
2014-03-19 |
2019-08-26 |
Boehringer Ingelheim Int |
Heteroaryl syk-hæmmere
|
WO2015197028A1
(en)
|
2014-06-28 |
2015-12-30 |
Sunshine Lake Pharma Co., Ltd. |
Compounds as hepatitis c virus (hcv) inhibitors and uses thereof in medicine
|
AU2015291522B2
(en)
|
2014-07-17 |
2018-12-06 |
Sunshine Lake Pharma Co., Ltd. |
Substituted urea derivatives and pharmaceutical uses thereof
|
JP6556146B2
(ja)
|
2014-08-26 |
2019-08-07 |
武田薬品工業株式会社 |
複素環化合物
|
GB201415573D0
(en)
|
2014-09-03 |
2014-10-15 |
Cancer Therapeutics Crc Pty Ltd |
Compounds
|
WO2016036636A1
(en)
|
2014-09-05 |
2016-03-10 |
Merck Sharp & Dohme Corp. |
Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
|
CN105461693B
(zh)
|
2014-09-26 |
2019-10-25 |
广东东阳光药业有限公司 |
Crth2拮抗剂化合物及其用途
|
JP6840666B2
(ja)
|
2014-10-03 |
2021-03-10 |
マヘーシュワリ, ディヴィヤMAHESHWARI, Divya |
新規なアントラニル酸誘導体
|
ES2578377B1
(es)
|
2014-12-22 |
2017-05-04 |
Consejo Superior De Investigaciones Científicas (Csic) |
Compuestos moduladores del sensor neuronal de calcio dream y sus usos terapéuticos.
|
US10407407B2
(en)
*
|
2015-05-21 |
2019-09-10 |
Glaxosmithkline Intellectual Property Development Limited |
Benzoimidazole derivatives as PAD4 inhibitors
|
EP4129278A1
(en)
|
2015-07-03 |
2023-02-08 |
Lars Klareskog |
Methods and compounds for the alleviation and/or prevention of bone loss and/or pain
|
WO2017024180A1
(en)
|
2015-08-06 |
2017-02-09 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
US10906897B2
(en)
|
2015-08-12 |
2021-02-02 |
Syngenta Participations Ag |
Microbiocidal heterobicyclic derivatives
|
CN112409378A
(zh)
|
2015-09-08 |
2021-02-26 |
豪夫迈·罗氏有限公司 |
三环pi3k抑制剂化合物及其使用方法
|
CN108617166B
(zh)
|
2015-10-21 |
2022-05-17 |
大冢制药株式会社 |
蛋白激酶抑制剂苯并内酰胺化合物
|
TW201726623A
(zh)
|
2015-12-17 |
2017-08-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
TW201730148A
(zh)
|
2015-12-22 |
2017-09-01 |
艾伯維德國有限兩合公司 |
作為s1p調節劑的稠合(雜)環化合物
|
EP3190103A1
(en)
|
2016-01-08 |
2017-07-12 |
Rijksuniversiteit Groningen |
Inhibitors of the pd-1/pd-l1 protein/protein interaction
|
EP3419969B1
(en)
|
2016-02-23 |
2019-12-18 |
Padlock Therapeutics, Inc. |
Heteroaryl inhibitors of pad4
|
EP3472158A1
(en)
|
2016-06-16 |
2019-04-24 |
Janssen Sciences Ireland Unlimited Company |
Heterocyclic compounds as antibacterials
|
PT3478662T
(pt)
|
2016-06-30 |
2020-12-09 |
Viiv Healthcare Uk No 5 Ltd |
Derivados de azadecalina como inibidores da replicação do vírus da imunodeficiência humana
|
CN110818690B
(zh)
|
2016-07-26 |
2021-08-10 |
深圳市塔吉瑞生物医药有限公司 |
用于抑制蛋白酪氨酸激酶活性的氨基嘧啶类化合物
|
JP2019530732A
(ja)
|
2016-08-03 |
2019-10-24 |
アライジング・インターナショナル・インコーポレイテッドArising International, Inc. |
免疫モジュレータとして有用な対称または半対称化合物
|
TWI795381B
(zh)
|
2016-12-21 |
2023-03-11 |
比利時商健生藥品公司 |
作為malt1抑制劑之吡唑衍生物
|
WO2018112843A1
(en)
|
2016-12-22 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
|
CN110099900B
(zh)
|
2016-12-27 |
2022-12-02 |
山东大学 |
针对Smoothened突变株的刺猬通路抑制剂
|
CN107056630B
(zh)
|
2017-01-23 |
2020-01-17 |
合肥工业大学 |
一种茚满类衍生物及其合成方法和在医药上的用途
|
EP3601245A1
(en)
|
2017-03-28 |
2020-02-05 |
The Regents of The University of Michigan |
Small molecule dcn1 inhibitors and therapeutic methods using the same
|
WO2018208985A2
(en)
|
2017-05-10 |
2018-11-15 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
CN107163044B
(zh)
|
2017-06-19 |
2021-04-23 |
广东药科大学 |
一类具有蛋白酶修饰活性的萘乙二酮化合物及其衍生物
|
WO2018234342A1
(en)
|
2017-06-21 |
2018-12-27 |
F. Hoffmann-La Roche Ag |
ISOINDOLINONE DERIVATIVES AS MODULATORS OF IRAK4
|
GB201710851D0
(en)
|
2017-07-06 |
2017-08-23 |
Galápagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
|
BR112020005489A2
(pt)
|
2017-09-22 |
2020-09-24 |
Jubilant Epipad Llc, |
composto da fórmula (i), composto de fórmula (ii), composto de fórmula (iii), processo de preparação de compostos de fórmula (i), processo de preparação de compostos de fórmula (ii), processo de preparação de compostos de fórmula (iii), composição farmacêutica, método para inibir uma ou mais famílias pad em uma célula, método para tratar uma afeção mediada por um ou mais pads, utilização do composto, método para o tratamento e/ou prevenção de uma afeção mediada por um ou mais distúrbios da família pad, método para o tratamento de artrite reumatoide e método de tratamento de câncer
|
MX2020003341A
(es)
|
2017-10-18 |
2020-09-17 |
Jubilant Epipad LLC |
Compuestos de imidazo-piridina como inhibidores de pad.
|
KR20200074164A
(ko)
|
2017-10-20 |
2020-06-24 |
반더빌트유니버시티 |
무스카린성 아세틸콜린 수용체 m4의 길항제
|
US11629135B2
(en)
|
2017-11-06 |
2023-04-18 |
Jubilant Prodell Llc |
Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
|
CN111542523B
(zh)
|
2017-11-24 |
2024-03-29 |
朱比连特埃皮斯科瑞有限责任公司 |
作为prmt5抑制剂的杂环化合物
|
JP7313354B2
(ja)
|
2017-12-19 |
2023-07-24 |
ブリストル-マイヤーズ スクイブ カンパニー |
Tlr阻害剤として有用なアミド置換されたインドール化合物
|
CN110117278B
(zh)
|
2018-02-07 |
2022-07-19 |
石家庄以岭药业股份有限公司 |
烷氧基苯并五元(六元)杂环胺类化合物及其药物用途
|
CN111727390B
(zh)
|
2018-02-14 |
2021-11-02 |
富士胶片株式会社 |
聚合性液晶组合物、光学膜、偏振片及图像显示装置
|
AU2019234185A1
(en)
|
2018-03-13 |
2020-10-01 |
Jubilant Prodel LLC. |
Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation
|
JP6956033B2
(ja)
|
2018-03-14 |
2021-10-27 |
日本化薬株式会社 |
ベンゾアゾール化合物、並びにこれを含んだ顔料組成物
|
CN108358917B
(zh)
|
2018-04-24 |
2020-06-19 |
北京市结核病胸部肿瘤研究所 |
含有碱性稠环片段的咪唑并[1,2-a]吡啶-3-酰胺类化合物及其制备方法
|
WO2019205147A1
(zh)
|
2018-04-28 |
2019-10-31 |
上海璃道医药科技有限公司 |
包含苯并含氧脂肪环结构的氨基乙酰胺类化合物及其用途
|
WO2019213234A1
(en)
|
2018-05-01 |
2019-11-07 |
The Trustees Of Columbia University In The City Of New York |
Triazolopyrimidines, their preparation and use
|
EP3829575A4
(en)
|
2018-08-01 |
2022-07-20 |
The Trustees of Columbia University in the City of New York |
RBP4 ANTAGONISTS FOR THE TREATMENT AND PREVENTION OF NON-ALCOHOLIC LIVER DISEASE AND GOUT
|
CN112689634A
(zh)
|
2018-08-06 |
2021-04-20 |
莫扎制药有限公司 |
Smad3抑制剂
|
WO2020045216A1
(ja)
|
2018-08-28 |
2020-03-05 |
富士フイルム株式会社 |
積層体および画像表示装置
|
CN110963997A
(zh)
|
2018-09-28 |
2020-04-07 |
四川科伦博泰生物医药股份有限公司 |
杂环酰胺类化合物、包含其的药物组合物及其制备方法和用途
|
EP3643711A1
(en)
|
2018-10-24 |
2020-04-29 |
Bayer Animal Health GmbH |
New anthelmintic compounds
|
AU2019373244B2
(en)
|
2018-10-30 |
2022-05-26 |
Gilead Sciences, Inc. |
Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
|
CN110105299B
(zh)
|
2019-01-23 |
2023-01-03 |
中山大学 |
一种含芳醚取代恶唑烷酮羧酸酯类衍生物及其制备方法和应用
|
JP2022528562A
(ja)
|
2019-04-05 |
2022-06-14 |
ストーム・セラピューティクス・リミテッド |
Mettl3阻害化合物
|
RU2717101C1
(ru)
|
2019-06-03 |
2020-03-18 |
Андрей Александрович Иващенко |
Анелированные 9-гидрокси-1,8-диоксо-1,3,4,8-тетрагидро-2Н-пиридо[1,2-a]пиразин-7-карбоксамиды - ингибиторы интегразы ВИЧ, способы их получения и применения
|
JP7420502B2
(ja)
|
2019-07-24 |
2024-01-23 |
住友化学株式会社 |
重合性液晶混合組成物、位相差板、楕円偏光板および有機el表示装置
|
AR119494A1
(es)
|
2019-07-29 |
2021-12-22 |
Servier Lab |
DERIVADOS DE 6,7-DIHIDRO-5H-PIRIDO[2,3-c]PIRIDAZIN-8-ILO, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SUS USOS COMO AGENTES PROAPOPTÓTICOS
|
WO2021028810A1
(en)
|
2019-08-09 |
2021-02-18 |
Inorbit Therapeutics Ab |
Sulfinic acid compounds as free fatty acid receptor agonists
|
JP7265024B2
(ja)
|
2019-09-27 |
2023-04-25 |
富士フイルム株式会社 |
液晶組成物、光学異方性層、光学フィルム、偏光板および画像表示装置
|
JP7182533B2
(ja)
|
2019-09-27 |
2022-12-02 |
富士フイルム株式会社 |
液晶組成物、光学異方性層、光学フィルム、偏光板および画像表示装置
|
US11811624B2
(en)
|
2019-11-15 |
2023-11-07 |
Mitsubishi Electric Corporation |
Edge device linking system, edge device linking method, and recording medium
|
EP4041733A4
(en)
|
2019-11-15 |
2023-08-30 |
Yuhan Corporation |
NOVEL DERIVATIVES CONTAINING 2,3-DIHYDRO-1H-INDENE OR 2,3-DIHYDROBENZOFUUR, OR A PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
CN111606904B
(zh)
|
2020-04-07 |
2021-10-15 |
广州医科大学 |
氮杂吲哚类化合物及其应用
|